A5019527757- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- COVID-19 and Mental Health
- Pediatric Pain Management Techniques
- Autoimmune and Inflammatory Disorders Research
- Diabetes Treatment and Management
- Heart Failure Treatment and Management
- Pancreatic function and diabetes
- COVID-19 and healthcare impacts
- Rheumatoid Arthritis Research and Therapies
- Pain Mechanisms and Treatments
- Radiation Dose and Imaging
- Ultrasound in Clinical Applications
- Multiple Sclerosis Research Studies
- Lipoproteins and Cardiovascular Health
- Anesthesia and Sedative Agents
- Sphingolipid Metabolism and Signaling
- Radiology practices and education
Deakin University
2025
Al Ain University
2022
Monash University
2020
Monash University Malaysia
2020
Radiography and medical students (RMS), upon graduation, require capabilities to provide life-saving care through identification communication of urgent findings on radiological imaging. This preliminary study investigated RMS' ability identify categorise CT examinations. It also explored their experiences image interpretation education. A sequential explanatory mixed-methods was employed. Participants were who had recently completed Year-4 (radiography/medicine) or Year-2 (medicine-only)...
Background: It would be rational to describe the pattern of clinical characteristics survivors and nonsurvivors during critical intensive-infection era coronavirus disease 2019 (COVID-19). The explicit objective current scoping review was delineate predictive risk factors associated with case fatality rate (CFR). Methods: Six retrospective studies subjects infected COVID-19 published between December 1, 2020, March 30, describing in Wuhan/Hubei, China, were identified. Results: There 1769 a...
Background: Tocilizumab is a novel interleukin-6 inhibitor that possesses some advantages over the other members of class and conventional therapy for rheumatoid arthritis. Aim review: The aim current protocol systematic review meta-analysis to assess efficacy safety tocilizumab. Methods: has been developed based on PRISMA-P checklist by using (PICO [population, intervention, comparators, outcome]) items, adult subjects who have received tocilizumab in randomized clinical trials. We will...
Background: Pitavastatin is a novel statin that possesses some advantages over conventional statin. Aim of the review: The subjects with primary or secondary cardiac events (population) receiving pitavastatin (intervention) will be compared to placebo other members (comparators), for non-inferiority superiority in terms effects on low-density lipoprotein-cholesterol (LDL-C), high-density (HDL-C), and/or major (outcome). Methods: protocol has been developed based PRISMA-P checklist by...